International Journal Of Bilogical Sciences
.: Home > International Journal Of Bilogical Sciences > 2014 > Volume 10 Number 10 > Bing-Jia Chen1, Yan-Ling Wu2, 1, Yoshimasa Tanaka3 and Wen Zhang1
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Bing-Jia Chen1, Yan-Ling Wu2, 1, Yoshimasa Tanaka3 and Wen Zhang1
1. Lab of Chemical Biology and Molecular Drug Design, College of Pharmaceutical Science, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, 310014, China. 2. Lab of Molecular Immunology, Virus Inspection Department, Zhejiang Provincial Center for Disease Control and Prevention, 630 Xincheng Road, Hangzhou, 310051, China. 3. Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, 606-8501, Japan. Corresponding authors: Wen Zhang, Department of Biopharmaceutical Science, College of Pharmaceutical Sciences, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, 310014, PR China; Tel: +86-571-88871507; Fax: +86-571-88871507; e-mail: firstname.lastname@example.org. Yan-Ling Wu, Lab of Molecular Immunology, Virus Inspection Department, Zhejiang Provincial Center for Disease Control and Prevention, 630 Xincheng Road, Hangzhou, 310051, PR China; Tel: +86-571-87115282; Fax: +86-571-87115282; e-mail: email@example.com; Both contributed equally to this work.
The nuclear transcription factor c-Myc is a member of the Myc gene family with multiple functions and located on band q24.1 of chromosome 8. The c-Myc gene is activated by chromosomal translocation, rearrangement, and amplification. Its encoded protein transduces intracellular signals to the nucleus, resulting in the regulation of cell proliferation, differentiation, and apoptosis, and has the ability to transform cells and bind chromosomal DNA. c-Myc also plays a critical role in malignant transformation. The abnormal over-expression of c-Myc is frequently observed in some tumors, including carcinomas of the breast, colon, and cervix, as well as small-cell lung cancer, osteosarcomas, glioblastomas, and myeloid leukemias, therefore making it a possible target for anticancer therapy. In this minireview, we summarize unique characteristics of c-Myc and therapeutic strategies against cancer using small molecules targeting the oncogene, and discuss the prospects in the development of agents targeting c-Myc, in particular G-quadruplexes formed in c-Myc promoter and c-Myc/Max dimerization. Such information will be of importance for the research and development of c-Myc-targeted drugs.
c-Myc; small molecule; targeted therapy; tumor, G-quadruplex
Date Deposited : 15 Feb 2016 11:03
Official URL: http://www.ijbs.com/v10i10
Last Modified : 15 Feb 2016 11:03
Volume 10, Number 10, - 2014 , ISSN 1449-2288
Full Text Original